nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.174	0.26	CbGbCtD
Granisetron—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.15	0.223	CbGbCtD
Granisetron—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.104	0.156	CbGbCtD
Granisetron—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.048	0.0715	CbGbCtD
Granisetron—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0439	0.0656	CbGbCtD
Granisetron—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0438	0.0653	CbGbCtD
Granisetron—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0407	0.0608	CbGbCtD
Granisetron—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0187	0.0279	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0184	0.0274	CbGbCtD
Granisetron—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0171	0.0256	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0117	0.0174	CbGbCtD
Granisetron—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.00667	0.325	CbGeAlD
Granisetron—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00508	0.248	CbGeAlD
Granisetron—HTR3A—nerve—peripheral nervous system neoplasm	0.0026	0.127	CbGeAlD
Granisetron—HTR3A—ganglion—peripheral nervous system neoplasm	0.00257	0.125	CbGeAlD
Granisetron—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00126	0.0615	CbGeAlD
Granisetron—HTR3A—brainstem—peripheral nervous system neoplasm	0.00112	0.0545	CbGeAlD
Granisetron—CYP1A1—parotid gland—peripheral nervous system neoplasm	0.000606	0.0295	CbGeAlD
Granisetron—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000411	0.02	CbGeAlD
Granisetron—Rash—Melphalan—peripheral nervous system neoplasm	0.000284	0.00092	CcSEcCtD
Granisetron—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000284	0.000919	CcSEcCtD
Granisetron—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.000916	CcSEcCtD
Granisetron—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000282	0.000913	CcSEcCtD
Granisetron—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000911	CcSEcCtD
Granisetron—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000909	CcSEcCtD
Granisetron—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000908	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00028	0.000906	CcSEcCtD
Granisetron—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000279	0.000902	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000898	CcSEcCtD
Granisetron—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000276	0.000892	CcSEcCtD
Granisetron—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000275	0.00089	CcSEcCtD
Granisetron—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.00089	CcSEcCtD
Granisetron—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.000886	CcSEcCtD
Granisetron—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.000886	CcSEcCtD
Granisetron—Nausea—Topotecan—peripheral nervous system neoplasm	0.000274	0.000885	CcSEcCtD
Granisetron—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000273	0.000883	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00088	CcSEcCtD
Granisetron—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000271	0.000878	CcSEcCtD
Granisetron—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000271	0.000878	CcSEcCtD
Granisetron—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00027	0.000875	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00087	CcSEcCtD
Granisetron—Infection—Etoposide—peripheral nervous system neoplasm	0.000269	0.000869	CcSEcCtD
Granisetron—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000868	CcSEcCtD
Granisetron—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.000867	CcSEcCtD
Granisetron—Nausea—Melphalan—peripheral nervous system neoplasm	0.000268	0.000867	CcSEcCtD
Granisetron—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000857	CcSEcCtD
Granisetron—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000265	0.000856	CcSEcCtD
Granisetron—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000264	0.000854	CcSEcCtD
Granisetron—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000854	CcSEcCtD
Granisetron—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000264	0.000854	CcSEcCtD
Granisetron—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000264	0.000854	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000852	CcSEcCtD
Granisetron—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000263	0.000851	CcSEcCtD
Granisetron—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000263	0.00085	CcSEcCtD
Granisetron—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000261	0.000846	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000843	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00084	CcSEcCtD
Granisetron—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00084	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000831	CcSEcCtD
Granisetron—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00083	CcSEcCtD
Granisetron—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000256	0.000827	CcSEcCtD
Granisetron—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.000826	CcSEcCtD
Granisetron—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000255	0.000824	CcSEcCtD
Granisetron—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000253	0.000817	CcSEcCtD
Granisetron—Pain—Cisplatin—peripheral nervous system neoplasm	0.000252	0.000817	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000814	CcSEcCtD
Granisetron—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000806	CcSEcCtD
Granisetron—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.000804	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000803	CcSEcCtD
Granisetron—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000246	0.000796	CcSEcCtD
Granisetron—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000793	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00079	CcSEcCtD
Granisetron—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000787	CcSEcCtD
Granisetron—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000243	0.000787	CcSEcCtD
Granisetron—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000243	0.000785	CcSEcCtD
Granisetron—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000241	0.00078	CcSEcCtD
Granisetron—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00024	0.000778	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000777	CcSEcCtD
Granisetron—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000239	0.000775	CcSEcCtD
Granisetron—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000237	0.000768	CcSEcCtD
Granisetron—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.000767	CcSEcCtD
Granisetron—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000236	0.000762	CcSEcCtD
Granisetron—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000235	0.00076	CcSEcCtD
Granisetron—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000233	0.000755	CcSEcCtD
Granisetron—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000755	CcSEcCtD
Granisetron—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000749	CcSEcCtD
Granisetron—Pain—Etoposide—peripheral nervous system neoplasm	0.000231	0.000748	CcSEcCtD
Granisetron—Constipation—Etoposide—peripheral nervous system neoplasm	0.000231	0.000748	CcSEcCtD
Granisetron—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000747	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000746	CcSEcCtD
Granisetron—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.000741	CcSEcCtD
Granisetron—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000228	0.000739	CcSEcCtD
Granisetron—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000737	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000728	CcSEcCtD
Granisetron—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000727	CcSEcCtD
Granisetron—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000725	CcSEcCtD
Granisetron—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000721	CcSEcCtD
Granisetron—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000223	0.000721	CcSEcCtD
Granisetron—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000222	0.000718	CcSEcCtD
Granisetron—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000221	0.000715	CcSEcCtD
Granisetron—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000221	0.000714	CcSEcCtD
Granisetron—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.000713	CcSEcCtD
Granisetron—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.000707	CcSEcCtD
Granisetron—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.000706	CcSEcCtD
Granisetron—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000703	CcSEcCtD
Granisetron—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000703	CcSEcCtD
Granisetron—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000702	CcSEcCtD
Granisetron—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000215	0.000695	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000693	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000692	CcSEcCtD
Granisetron—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000214	0.000692	CcSEcCtD
Granisetron—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000214	0.000692	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000691	CcSEcCtD
Granisetron—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000212	0.000687	CcSEcCtD
Granisetron—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000685	CcSEcCtD
Granisetron—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000682	CcSEcCtD
Granisetron—Rash—Vincristine—peripheral nervous system neoplasm	0.00021	0.000681	CcSEcCtD
Granisetron—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00021	0.00068	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000678	CcSEcCtD
Granisetron—Headache—Vincristine—peripheral nervous system neoplasm	0.000209	0.000676	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000673	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000671	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000667	CcSEcCtD
Granisetron—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000206	0.000666	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000665	CcSEcCtD
Granisetron—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000202	0.00987	CbGeAlD
Granisetron—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000202	0.000653	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00065	CcSEcCtD
Granisetron—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000199	0.000644	CcSEcCtD
Granisetron—Nausea—Vincristine—peripheral nervous system neoplasm	0.000198	0.000641	CcSEcCtD
Granisetron—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000641	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00064	CcSEcCtD
Granisetron—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000194	0.000628	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000628	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000626	CcSEcCtD
Granisetron—Chills—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000619	CcSEcCtD
Granisetron—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000191	0.000619	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000617	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000615	CcSEcCtD
Granisetron—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00061	CcSEcCtD
Granisetron—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000607	CcSEcCtD
Granisetron—Rash—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000602	CcSEcCtD
Granisetron—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000601	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000601	CcSEcCtD
Granisetron—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000185	0.000599	CcSEcCtD
Granisetron—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000593	CcSEcCtD
Granisetron—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000592	CcSEcCtD
Granisetron—Tension—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00059	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000588	CcSEcCtD
Granisetron—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000584	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000579	CcSEcCtD
Granisetron—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000179	0.000578	CcSEcCtD
Granisetron—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000573	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00057	CcSEcCtD
Granisetron—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000567	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000564	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000557	CcSEcCtD
Granisetron—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000172	0.000556	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000556	CcSEcCtD
Granisetron—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000555	CcSEcCtD
Granisetron—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000552	CcSEcCtD
Granisetron—Rash—Etoposide—peripheral nervous system neoplasm	0.00017	0.000552	CcSEcCtD
Granisetron—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00017	0.000551	CcSEcCtD
Granisetron—Headache—Etoposide—peripheral nervous system neoplasm	0.000169	0.000548	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000548	CcSEcCtD
Granisetron—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000546	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000544	CcSEcCtD
Granisetron—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000542	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.00054	CcSEcCtD
Granisetron—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00054	CcSEcCtD
Granisetron—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000539	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000538	CcSEcCtD
Granisetron—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000531	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000528	CcSEcCtD
Granisetron—Cough—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000524	CcSEcCtD
Granisetron—Nausea—Etoposide—peripheral nervous system neoplasm	0.000161	0.00052	CcSEcCtD
Granisetron—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000519	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000516	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000514	CcSEcCtD
Granisetron—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000512	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000512	CcSEcCtD
Granisetron—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000511	CcSEcCtD
Granisetron—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00051	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000508	CcSEcCtD
Granisetron—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000505	CcSEcCtD
Granisetron—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000501	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000155	0.0005	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000499	CcSEcCtD
Granisetron—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000499	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000498	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000491	CcSEcCtD
Granisetron—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00049	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00049	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000489	CcSEcCtD
Granisetron—Infection—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000487	CcSEcCtD
Granisetron—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000485	CcSEcCtD
Granisetron—Shock—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000482	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000481	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00048	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00048	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000479	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000476	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000474	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000473	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000473	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000472	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00047	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000468	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000463	CcSEcCtD
Granisetron—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000458	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000454	CcSEcCtD
Granisetron—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000454	CcSEcCtD
Granisetron—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000451	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000447	CcSEcCtD
Granisetron—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000446	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000445	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000444	CcSEcCtD
Granisetron—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000443	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000443	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000441	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00044	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000439	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000437	CcSEcCtD
Granisetron—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000436	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000432	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000426	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000424	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000423	CcSEcCtD
Granisetron—Pain—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000419	CcSEcCtD
Granisetron—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000419	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000413	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00041	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000407	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000404	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000404	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000403	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000401	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000399	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000394	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000392	CcSEcCtD
Granisetron—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00039	CcSEcCtD
Granisetron—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000388	CcSEcCtD
Granisetron—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000388	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000388	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000388	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000374	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000371	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000361	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00036	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000359	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000359	CcSEcCtD
Granisetron—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000352	CcSEcCtD
Granisetron—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000347	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000335	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000334	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000326	CcSEcCtD
Granisetron—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000324	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000321	CcSEcCtD
Granisetron—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000312	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.00031	CcSEcCtD
Granisetron—Rash—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000309	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000309	CcSEcCtD
Granisetron—Headache—Epirubicin—peripheral nervous system neoplasm	9.49e-05	0.000307	CcSEcCtD
Granisetron—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.0003	CcSEcCtD
Granisetron—Nausea—Epirubicin—peripheral nervous system neoplasm	9e-05	0.000291	CcSEcCtD
Granisetron—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000288	CcSEcCtD
Granisetron—Rash—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000286	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000286	CcSEcCtD
Granisetron—Headache—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.000284	CcSEcCtD
Granisetron—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.000269	CcSEcCtD
